US FDA 510(k) Surface Use Market Clearance
Emergency and therapeutic use in the control of bleeding from the skin and other surface wounds where temporary control of bleeding is required.
BloodSTOP® iX Trauma Matrix is indicated for external temporary control of minor to moderate bleeding of traumatic wounds.
Control of surface bleeding from minor cuts and abrasions of the skin surface
CE Mark (EU) Absorbable Implant Use Approval (BloodSTOP® iX only)
Absorbable, implantable use for the control of bleeding during and after surgery, for the general population and for those on anticoagulant medications.
ISO 13485:2016 Certification
International Quality System Standard for Medical Device Manufacturing